Filing Details
- Accession Number:
- 0001140361-16-063350
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-04 16:16:51
- Reporting Period:
- 2016-04-29
- Filing Date:
- 2016-05-04
- Accepted Time:
- 2016-05-04 16:16:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1557533 | Robert Jeffrey Ajer | C/O Biomarin Pharmaceutical Inc., 105 Digital Drive Novato CA 94949 | Evp, Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-04-29 | 415 | $51.26 | 63,487 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2016-05-03 | 415 | $86.03 | 63,072 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- The reporting person is reporting the purchase of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 1, 2015 to April 30, 2016.
- Transaction made pursuant to a Rule 10b5-1 trading plan executed on May 11, 2015.
- The price in column 4 is a weighted average price. The price actually received ranged from $85.32 to $86.85. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range
Billionaire Hedge Funds
